Skip to main content
Clinical Trials/NCT05063487
NCT05063487
Completed
Not Applicable

Evaluating the Impact of HIV-1 Recent Infection Testing on Incremental HIV Testing Yield and Adverse Events Linked to Return of Recent Infection Testing Results in Rwanda

Columbia University1 site in 1 country1,588 target enrollmentJuly 29, 2021
ConditionsHIV Infections

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
HIV Infections
Sponsor
Columbia University
Enrollment
1588
Locations
1
Primary Endpoint
The incidence of intimate partner violence associated with the return of recency testing results among people newly diagnosed with HIV that test recent versus long-term
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The study is a longitudinal, observational cohort study of people who are newly-diagnosed with HIV who consent to recency testing and participate in index testing services, and their disclosed contacts.

The study will evaluate the impact of recency testing on HIV positive yield of index testing among the contacts of newly diagnosed people living with HIV and the incidence of adverse events or social harm as a result of returning recency results among newly diagnosed people living with HIV.

Detailed Description

The rapid test for recent HIV infection (RTRI) assay can distinguish between people who are recently-infected and those who are long-term HIV cases. This may help guide efforts to identify ongoing HIV transmission and direct prevention or treatment efforts. But, more research is needed on the impact of RTRI on the number of HIV+ individuals that can be identified through testing. Furthermore, not much is known about the impact that returning RTRI results may have on the occurrence of intimate partner violence. A primary objective of this study is to compare the HIV testing yield among contacts of people newly diagnosed with HIV by recency testing result. The investigators will abstract routinely collected data from participant medical records and registers. In addition, a second primary objective of this study is to assess the incidence of intimate partner violence associated with the return of recency testing results among those classified as testing recent versus long-term. Index study participants newly diagnosed with HIV will be interviewed at the initial enrollment visit following HIV diagnosis and during follow-up visits at 1, 2, and 6-months using a health-related quality of life instrument and intimate partner violence questionnaire. Participants will be recruited from 60 high-volume facilities across all provinces in Rwanda during the evaluation period.

Registry
clinicaltrials.gov
Start Date
July 29, 2021
End Date
October 31, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Suzue Saito

Associate Research Scientist in ICAP

Columbia University

Eligibility Criteria

Inclusion Criteria

  • Aged ≥15 years
  • Be newly diagnosed with HIV
  • Ability to speak and understand English or Kinyarwanda
  • Consented to be part of both case-based surveillance (CBS) (which includes PNS) and recency surveillance under the separate, approved CBS protocol.
  • Give voluntary written informed consent for data collection via semi-structured interview and survey instruments
  • Give voluntary written informed consent for use of routinely collected data
  • Be female if they are received at the facility at the same time as their partner (for intimate partner violence objective only).

Exclusion Criteria

  • Opt out or do not consent, or are unable to consent to participate in semi-structured interviews and completion of survey instruments
  • Have a history of testing HIV positive (i.e., not newly diagnosed with HIV)
  • Report antiretroviral drug (ARV) use for HIV management at any point during the HIV testing service (HTS) visit

Outcomes

Primary Outcomes

The incidence of intimate partner violence associated with the return of recency testing results among people newly diagnosed with HIV that test recent versus long-term

Time Frame: From baseline to 6 months after initial HIV diagnosis

We will compare the incremental change in intimate partner violence resulting from the return of recency testing results between 2 and 6 months, adjusting for baseline and 1 month follow-up.

The HIV positive yield of index testing among the contacts of people newly diagnosed with HIV that test recent versus long-term.

Time Frame: From baseline to 6 months after initial diagnosis

We will compare the number of HIV positive contacts that are linked to HIV recent vs. long-term index cases newly diagnosed with HIV.

Study Sites (1)

Loading locations...

Similar Trials